Chemotargets Announces First AI-Designed Drug for Huntington’s Disease to Enter Clinical Trials

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

This is a Biotech company founded in 2006 by Dr. Jordi Mestres as a spin-off from the Hospital del Mar Medical Research Institute (IMIM)

Read more

Apathy as an indicator of progression in Huntington's disease

by Hospital Universitari de Bellvitge

IDIBELL-UB researchers associate changes in white matter connectivity in different subtypes of apathy, one of the most common psychiatric syndromes in Huntington's disease (HD)

Read more

Researchers discover the role of tau protein in Huntington's disease

by Professional Newco

Huntington's disease is a neurodegenerative disorder that causes involuntary movements, psychiatric disturbances, and dementia, caused by a mutation in the huntingtin gene (HTT) consisting of expansio...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream